Julie Ngai is a Principal at Blue Owl Capital, whose known portfolio counts 10 companies.
Is Julie Ngai a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
Contacts
Affiliated funds' portfolios
Principal at Blue Owl Capital, whose known portfolio counts 10 companies
- Mirador Therapeutics
- Pyxis Oncology
- Vestwell
- BridgeBio
- Obsidian Therapeutics
- RLDatix
- enGene
- Alterome Therapeutics
- Monotype
- XOMA
Investor Profile
Founders in the listed sectors FinTech, Healthcare, Real Estate and SaaS, and focus areas Biotech, Cybersecurity, Data Analytics and Direct Lending fall inside that listing.
Blue Owl Capital appears in Growth, Late-Stage and Series A rounds across its known deals.
What the affiliated firm has backed is the closest available signal on whether Julie Ngai is worth approaching.
Colleagues at Blue Owl Capital
Showing 20 of 42
Neel Doppalapudi
Principal
New York, United States
Sara Clarke
Biotech Venture Capital
New York, United States
Christopher Marino
Principal
New York City, United States
Sandip Agarwala
Managing Director
New York, United States
Fabrice Fiol
Investor
New York, United States
Sacha Gornaya
Managing Director
London, United Kingdom
Shari Withem
Managing Director
New York, United States
Daniel Rosato
Managing Director
New York City, United States
Marc Lipschultz
Chief Executive Officer
United States
David Hall
Principal
New York, United States
Pravin Vazirani
Managing Director
Atherton, United States
Thomas Lovinger
Investor
New York, United States
Alex Jones
Managing Director
New York, United States
Alexey Teplukhin
Managing Director
New York City, United States
Brian Finkelstein
Managing Director
New York, United States
Mark Schachter
Managing Director
Dallas, United States
Brendan Kelly
Managing Director
New York, United States
Cara Griffiths
Managing Director
London, United Kingdom
Alyssa Twomey
Principal, Institutional Capital
New York, United States
Sohail Lalani
Managing Director
Abu Dhabi, United Arab Emirates
Frequently asked questions
Who is Julie Ngai?
Julie Ngai is a private equity investor and venture debt investor based in New York, United States, listed as Principal at Blue Owl Capital. The known portfolio of that firm counts 10 companies. That portfolio belongs to the firm, not to Julie Ngai personally.
What does Julie Ngai invest in?
Listed sectors include FinTech, Healthcare, Real Estate and SaaS; listed focus areas include Biotech, Cybersecurity, Data Analytics and Direct Lending. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Julie Ngai invest at?
Blue Owl Capital appears in Growth, Late-Stage and Series A rounds across its known deals, and Julie Ngai is listed there as Principal. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Julie Ngai listed at?
Julie Ngai is listed as Principal at Blue Owl Capital. 42 other people in the database share a firm with Julie Ngai.
How do I contact Julie Ngai?
An email address, a phone number and a LinkedIn page are on file for Julie Ngai. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal